Loading...
Header Logo
Keywords
Last Name
Institution

CARLOS ANTONIO TORRES CABALA

TitleAssociate Professor
InstitutionMD Anderson
DepartmentPathology
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Namikawa K, Aung PP, Milton DR, Tetzlaff MT, Torres Cabala CA, Curry JL, Nagarajan P, Ivan D, Ross MI, Gershenwald JE, Prieto VG. Correlation of tumor burden in sentinel lymph nodes with tumor burden in non-sentinel lymph nodes and survival in cutaneous melanoma. Clin Cancer Res. 2019 Sep 30. PMID: 31570567.
      View in: PubMed
    2. Wieser I, Tetzlaff MT, Torres Cabala CA, Duvic M. Primary cutaneous CD30(+) lymphoproliferative disorders. J Dtsch Dermatol Ges. 2016 Aug; 14(8):767-82. PMID: 27509411.
      View in: PubMed
    3. Feldmeyer L, Tetzlaff M, Fox P, Nagarajan P, Curry J, Ivan D, Torres Cabala CA, Prieto VG, Aung PP. Prognostic Implication of Lymphovascular Invasion Detected by Double Immunostaining for D2-40 and MITF1 in Primary Cutaneous Melanoma. Am J Dermatopathol. 2016 Jul; 38(7):484-91. PMID: 26675354.
      View in: PubMed
    4. Ramani NS, Curry JL, Kapil J, Rapini RP, Tetzlaff MT, Prieto VG, Torres-Cabala CA. Panniculitis With Necrotizing Granulomata in a Patient on BRAF Inhibitor (Dabrafenib) Therapy for Metastatic Melanoma. Am J Dermatopathol. 2015 Aug; 37(8):e96-9. PMID: 25839886.
      View in: PubMed
    5. Tetzlaff MT, Pattanaprichakul P, Wargo J, Fox PS, Patel KP, Estrella JS, Broaddus RR, Williams MD, Davies MA, Routbort MJ, Lazar AJ, Woodman SE, Hwu WJ, Gershenwald JE, Prieto VG, Torres-Cabala CA, Curry JL. Utility of BRAF V600E Immunohistochemistry Expression Pattern as a Surrogate of BRAF Mutation Status in 154 Patients with Advanced Melanoma. Hum Pathol. 2015 Aug; 46(8):1101-10. PMID: 26058727.
      View in: PubMed
    6. Stockman DL, Curry JL, Torres-Cabala CA, Watson IR, Siroy AE, Bassett RL, Zou L, Patel KP, Luthra R, Davies MA, Wargo JA, Routbort MA, Broaddus RR, Prieto VG, Lazar AJ, Tetzlaff MT. Use of clinical next-generation sequencing to identify melanomas harboring SMARCB1 mutations. J Cutan Pathol. 2015 May; 42(5):308-17. PMID: 25754356.
      View in: PubMed
    7. Torres-Cabala CA, Curry JL, Li Ning Tapia EM, Ramos C, Tetzlaff MT, Prieto VG, Miranda RN, Bravo F. HTLV-1-associated infective dermatitis demonstrates low frequency of FOXP3-positive T-regulatory lymphocytes. J Dermatol Sci. 2015 Mar; 77(3):150-5. PMID: 25676425.
      View in: PubMed
    8. de la Garza Bravo MM, Patel KP, Loghavi S, Curry JL, Torres Cabala CA, Cason RC, Gangar P, Prieto VG, Medeiros LJ, Duvic M, Tetzlaff MT. Shared clonality in distinctive lesions of lymphomatoid papulosis and mycosis fungoides occurring in the same patients suggests a common origin. Hum Pathol. 2015 Apr; 46(4):558-69. PMID: 25666664.
      View in: PubMed
    9. Beltrán BE, Castillo JJ, Quiñones P, Morales D, Paredes A, Nieto G, Miranda RN, Torres-Cabala CA. Extranodal marginal zone lymphoma from ocular adnexae with subcutaneous involvement. Am J Dermatopathol. 2014 Nov; 36(11):e189-93. PMID: 25238445.
      View in: PubMed
    10. Henderson SA, Torres-Cabala CA, Curry JL, Bassett RL, Ivan D, Prieto VG, Tetzlaff MT. p40 is more specific than p63 for the distinction of atypical fibroxanthoma from other cutaneous spindle cell malignancies. Am J Surg Pathol. 2014 Aug; 38(8):1102-10. PMID: 25029117.
      View in: PubMed
    11. Kim CY, Kim DW, Kim K, Curry J, Torres-Cabala C, Patel S. GNAQ mutation in a patient with metastatic mucosal melanoma. BMC Cancer. 2014 Jul 16; 14:516. PMID: 25030020.
      View in: PubMed
    12. Curry JL, Tetzlaff MT, Nicholson K, Duvic M, Kim KB, Tsai KY, Hwu WJ, Hong DS, Prieto VG, Torres-Cabala CA. Histological features associated with vemurafenib-induced skin toxicities: examination of 141 cutaneous lesions biopsied during therapy. Am J Dermatopathol. 2014 Jul; 36(7):557-61. PMID: 24950418.
      View in: PubMed
    13. Le Loarer F, Barete S, Vallat L, Carre D, El Amarti R, Torres-Cabala C, Cacoub P, Sene D, Courville P, Bravard P. Primary cutaneous CD8+ T-cell lymphoma masquerading as acral vascular syndrome. Acta Derm Venereol. 2014 May; 94(3):317-9. PMID: 23995595.
      View in: PubMed
    14. Loghavi S, Curry JL, Torres-Cabala CA, Ivan D, Patel KP, Mehrotra M, Bassett R, Prieto VG, Tetzlaff MT. Melanoma arising in association with blue nevus: a clinical and pathologic study of 24 cases and comprehensive review of the literature. Mod Pathol. 2014 Nov; 27(11):1468-78. PMID: 24743221.
      View in: PubMed
    15. De la Garza Bravo MM, Curry JL, Torres-Cabala CA, Ivan DS, Drucker C, Prieto VG, Tetzlaff MT. Pigmented extramammary Paget disease of the thigh mimicking a melanocytic tumor: report of a case and review of the literature. J Cutan Pathol. 2014 Jun; 41(6):529-35. PMID: 24698435.
      View in: PubMed
    16. Buonaccorsi JN, Prieto VG, Torres-Cabala C, Suster S, Plaza JA. Diagnostic utility and comparative immunohistochemical analysis of MITF-1 and SOX10 to distinguish melanoma in situ and actinic keratosis: a clinicopathological and immunohistochemical study of 70 cases. Am J Dermatopathol. 2014 Feb; 36(2):124-30. PMID: 23782678.
      View in: PubMed
    17. Wright NA, Torres-Cabala CA, Curry JL, Cutlan JE, Hymes SR. Post-varicella-zoster virus granulomatous dermatitis: a report of 2 cases. Cutis. 2014 Jan; 93(1):50-4. PMID: 24505586.
      View in: PubMed
    18. Pattanaprichakul P, Tetzlaff MT, Lapolla WJ, Torres-Cabala CA, Duvic M, Prieto VG, Tsai KY, Curry JL. Sweet syndrome following vemurafenib therapy for recurrent cholangiocarcinoma. J Cutan Pathol. 2014 Mar; 41(3):326-8. PMID: 24372055.
      View in: PubMed
    19. Chu VH, Tetzlaff MT, Torres-Cabala CA, Prieto VG, Bassett R, Gershenwald JE, McLemore MS, Ivan D, Wang WL, Ross MI, Curry JL. Impact of the 2009 (7th edition) AJCC melanoma staging system in the classification of thin cutaneous melanomas. Biomed Res Int. 2013; 2013:898719. PMID: 24369020.
      View in: PubMed
    20. Tetzlaff MT, Wang WL, Milless TL, Curry JL, Torres-Cabala CA, McLemore MS, Ivan D, Bassett RL, Prieto VG. Ambiguous melanocytic tumors in a tertiary referral center: the contribution of fluorescence in situ hybridization (FISH) to conventional histopathologic and immunophenotypic analyses. Am J Surg Pathol. 2013 Dec; 37(12):1783-96. PMID: 24061523.
      View in: PubMed
    21. Nava VE, Torres-Cabala C. Novel intra-adrenal secondary lymphoid follicle formation. Endocr Pathol. 2013 Dec; 24(4):248-9. PMID: 24014039.
      View in: PubMed
    22. Aung PP, Climent F, Muzzafar T, Curry JL, Patel KP, Servitje O, Prieto VG, Duvic M, Jaffe ES, Torres-Cabala CA. Immunophenotypic shift of CD4 and CD8 antigen expression in primary cutaneous T-cell lymphomas: a clinicopathologic study of three cases. J Cutan Pathol. 2014 Jan; 41(1):51-7. PMID: 24151865.
      View in: PubMed
    23. McQuitty E, Curry JL, Tetzlaff MT, Prieto VG, Duvic M, Torres-Cabala C. The differential diagnosis of CD8-positive ("type D") lymphomatoid papulosis. J Cutan Pathol. 2014 Feb; 41(2):88-100. PMID: 24118002.
      View in: PubMed
    24. Curry JL, Torres-Cabala CA, Kim KB, Tetzlaff MT, Duvic M, Tsai KY, Hong DS, Prieto VG. Dermatologic toxicities to targeted cancer therapy: shared clinical and histologic adverse skin reactions. Int J Dermatol. 2014 Mar; 53(3):376-84. PMID: 23879247.
      View in: PubMed
    25. Tetzlaff MT, Curry JL, Ivan D, Wang WL, Torres-Cabala CA, Bassett RL, Valencia KM, McLemore MS, Ross MI, Prieto VG. Immunodetection of phosphohistone H3 as a surrogate of mitotic figure count and clinical outcome in cutaneous melanoma. Mod Pathol. 2013 Sep; 26(9):1153-60. PMID: 23558574.
      View in: PubMed
    26. Curry JL, Falchook GS, Hwu WJ, Torres-Cabala CA, Duvic M, Tetzlaff MT, Prieto VG. Changes in tumor morphology and cyclin-dependent kinase inhibitor expression in metastatic melanoma treated with selective second-generation BRAF inhibitor. Am J Dermatopathol. 2013 Feb; 35(1):125-8. PMID: 22878367.
      View in: PubMed
    27. Curry JL, Torres-Cabala CA, Tetzlaff MT, Bowman C, Prieto VG. Molecular platforms utilized to detect BRAF V600E mutation in melanoma. Semin Cutan Med Surg. 2012 Dec; 31(4):267-73. PMID: 23174497.
      View in: PubMed
    28. Rose CL, Chakravarti N, Curry JL, Torres-Cabala CA, Bassett R, Prieto VG, Tetzlaff MT. The utility of ATF3 in distinguishing cutaneous squamous cell carcinoma among other cutaneous epithelial neoplasms. J Cutan Pathol. 2012 Aug; 39(8):762-8. PMID: 22764884.
      View in: PubMed
    29. Zhang YH, Wang WL, Rapini RP, Torres-Cabala C, Prieto VG, Curry JL. Syringocystadenocarcinoma papilliferum with transition to areas of squamous differentiation: a case report and review of the literature. Am J Dermatopathol. 2012 Jun; 34(4):428-33. PMID: 22343110.
      View in: PubMed
    30. Shirley SH, Greene VR, Duncan LM, Torres Cabala CA, Grimm EA, Kusewitt DF. Slug expression during melanoma progression. Am J Pathol. 2012 Jun; 180(6):2479-89. PMID: 22503751.
      View in: PubMed
    31. McLemore MS, Bruner JM, Curry JL, Prieto VG, Torres-Cabala CA. Anaplastic oligodendroglioma involving the subcutaneous tissue of the scalp: report of an exceptional case and review of the literature. Am J Dermatopathol. 2012 Apr; 34(2):214-9. PMID: 22157246.
      View in: PubMed
    32. Williams VL, Torres-Cabala CA, Duvic M. Primary cutaneous small- to medium-sized CD4+ pleomorphic T-cell lymphoma: a retrospective case series and review of the provisional cutaneous lymphoma category. Am J Clin Dermatol. 2011 Dec 01; 12(6):389-401. PMID: 21863906.
      View in: PubMed
    33. McLemore MS, Huo L, Deavers MT, Curry JL, Torres-Cabala CA, Wang WL, Prieto VG. Cutaneous epithelioid angiomatous nodule of the chest wall with expression of estrogen receptor: a mimic of carcinoma and a potential diagnostic pitfall. J Cutan Pathol. 2011 Oct; 38(10):818-22. PMID: 21752053.
      View in: PubMed
    34. Rashid RM, Torres-Cabala C, Chon S. Longitudinal erythronychia: the value of cosmetic alterations in nail findings. Skinmed. 2011 Jan-Feb; 9(1):60-1. PMID: 21409965.
      View in: PubMed
    35. Diamantis ML, Richmond HM, Rady PL, Tyring SK, Cutlan JE, Torres-Cabala C, Hymes SR. Detection of human papillomavirus in multiple eccrine poromas in a patient with chronic graft-vs-host disease and immunosuppression. Arch Dermatol. 2011 Jan; 147(1):120-2. PMID: 21242407.
      View in: PubMed
    36. Savar A, Oellers P, Myers J, Prieto VG, Torres-Cabala C, Frank SJ, Ivan D, Esmaeli B. Positive sentinel node in sebaceous carcinoma of the eyelid. Ophthalmic Plast Reconstr Surg. 2011 Jan-Feb; 27(1):e4-6. PMID: 20940661.
      View in: PubMed
    37. Cutlan JE, Rashid RM, Torres-Cabala C, Tyring SK, Thomas V. Epidermodysplasia verruciformis after cutaneous T-cell lymphoma: Periungual presentation. Dermatol Online J. 2010 Aug 15; 16(8):12. PMID: 20804689.
      View in: PubMed
    38. Geddes ER, Polder K, Cutlan JE, Torres-Cabala CA, Hymes SR. Ulcerated plaque under a ruby ring in an immunosuppressed patient. Dermatol Online J. 2010 Aug 15; 16(8):4. PMID: 20804681.
      View in: PubMed
    39. Plaza JA, Torres-Cabala C, Evans H, Diwan HA, Suster S, Prieto VG. Cutaneous metastases of malignant melanoma: a clinicopathologic study of 192 cases with emphasis on the morphologic spectrum. Am J Dermatopathol. 2010 Apr; 32(2):129-36. PMID: 20010406.
      View in: PubMed
    40. Torres-Cabala CA, Wang WL, Trent J, Yang D, Chen S, Galbincea J, Kim KB, Woodman S, Davies M, Plaza JA, Nash JW, Prieto VG, Lazar AJ, Ivan D. Correlation between KIT expression and KIT mutation in melanoma: a study of 173 cases with emphasis on the acral-lentiginous/mucosal type. Mod Pathol. 2009 Nov; 22(11):1446-56. PMID: 19718013.
      View in: PubMed
    41. Torres-Cabala CA, Plaza JA, Diwan AH, Prieto VG. Severe architectural disorder is a potential pitfall in the diagnosis of small melanocytic lesions. J Cutan Pathol. 2010 Aug; 37(8):860-5. PMID: 19614731.
      View in: PubMed
    42. Plaza JA, Torres-Cabala C, Evans H, Diwan AH, Prieto VG. Immunohistochemical expression of S100A6 in cellular neurothekeoma: clinicopathologic and immunohistochemical analysis of 31 cases. Am J Dermatopathol. 2009 Jul; 31(5):419-22. PMID: 19542912.
      View in: PubMed
    43. Plaza JA, Torres-Cabala C, Ivan D, Prieto VG. HER-2/neu expression in extramammary Paget disease: a clinicopathologic and immunohistochemistry study of 47 cases with and without underlying malignancy. J Cutan Pathol. 2009 Jul; 36(7):729-33. PMID: 19519604.
      View in: PubMed
    44. Shanti RM, Torres-Cabala CA, Jaffe ES, Wilson WH, Brahim JS. Lymphomatoid granulomatosis with involvement of the hard palate: a case report. J Oral Maxillofac Surg. 2008 Oct; 66(10):2161-3. PMID: 18848119.
      View in: PubMed
    45. Merino MJ, Torres-Cabala C, Pinto P, Linehan WM. The morphologic spectrum of kidney tumors in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome. Am J Surg Pathol. 2007 Oct; 31(10):1578-85. PMID: 17895761.
      View in: PubMed
    46. Grubb RL, Franks ME, Toro J, Middelton L, Choyke L, Fowler S, Torres-Cabala C, Glenn GM, Choyke P, Merino MJ, Zbar B, Pinto PA, Srinivasan R, Coleman JA, Linehan WM. Hereditary leiomyomatosis and renal cell cancer: a syndrome associated with an aggressive form of inherited renal cancer. J Urol. 2007 Jun; 177(6):2074-9; discussion 2079-80. PMID: 17509289.
      View in: PubMed
    47. Schinstine M, Filie AC, Torres-Cabala C, Abati A, Linehan WM, Merino M. Fine-needle aspiration of a Xp11.2 translocation/TFE3 fusion renal cell carcinoma metastatic to the lung: report of a case and review of the literature. Diagn Cytopathol. 2006 Nov; 34(11):751-6. PMID: 17121198.
      View in: PubMed
    48. Torres-Cabala C, Bibbo M, Panizo-Santos A, Barazi H, Krutzsch H, Roberts DD, Merino MJ. Proteomic identification of new biomarkers and application in thyroid cytology. Acta Cytol. 2006 Sep-Oct; 50(5):518-28. PMID: 17017437.
      View in: PubMed
    49. Schinstine M, Torres-Cabala C, Brosky K, Roth MJ. Ganglion cyst in a 52-year-old man with metastatic melanoma. Diagn Cytopathol. 2006 Jul; 34(7):485. PMID: 16783777.
      View in: PubMed
    50. Kim CM, Vocke C, Torres-Cabala C, Yang Y, Schmidt L, Walther M, Linehan WM. Expression of hypoxia inducible factor-1alpha and 2alpha in genetically distinct early renal cortical tumors. J Urol. 2006 May; 175(5):1908-14. PMID: 16600797.
      View in: PubMed
    51. Li-Ning-T E, Ronchetti R, Torres-Cabala C, Merino MJ. Role of chromogenic in situ hybridization (CISH) in the evaluation of HER2 status in breast carcinoma: comparison with immunohistochemistry and FISH. Int J Surg Pathol. 2005 Oct; 13(4):343-51. PMID: 16273190.
      View in: PubMed
    52. Isaacs JS, Jung YJ, Mole DR, Lee S, Torres-Cabala C, Chung YL, Merino M, Trepel J, Zbar B, Toro J, Ratcliffe PJ, Linehan WM, Neckers L. HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability. Cancer Cell. 2005 Aug; 8(2):143-53. PMID: 16098467.
      View in: PubMed
    53. Vocke CD, Yang Y, Pavlovich CP, Schmidt LS, Nickerson ML, Torres-Cabala CA, Merino MJ, Walther MM, Zbar B, Linehan WM. High frequency of somatic frameshift BHD gene mutations in Birt-Hogg-Dubé-associated renal tumors. J Natl Cancer Inst. 2005 Jun 15; 97(12):931-5. PMID: 15956655.
      View in: PubMed
    54. Pavlovich CP, Grubb RL, Hurley K, Glenn GM, Toro J, Schmidt LS, Torres-Cabala C, Merino MJ, Zbar B, Choyke P, Walther MM, Linehan WM. Evaluation and management of renal tumors in the Birt-Hogg-Dubé syndrome. J Urol. 2005 May; 173(5):1482-6. PMID: 15821464.
      View in: PubMed
    55. Alleman WG, Tabios RL, Chandramouli GV, Aprelikova ON, Torres-Cabala C, Mendoza A, Rogers C, Rodgers C, Sopko NA, Linehan WM, Vasselli JR. The in vitro and in vivo effects of re-expressing methylated von Hippel-Lindau tumor suppressor gene in clear cell renal carcinoma with 5-aza-2'-deoxycytidine. Clin Cancer Res. 2004 Oct 15; 10(20):7011-21. PMID: 15501981.
      View in: PubMed
    56. Schmidt LS, Nickerson ML, Angeloni D, Glenn GM, Walther MM, Albert PS, Warren MB, Choyke PL, Torres-Cabala CA, Merino MJ, Brunet J, Bérez V, Borràs J, Sesia G, Middelton L, Phillips JL, Stolle C, Zbar B, Pautler SE, Linehan WM. Early onset hereditary papillary renal carcinoma: germline missense mutations in the tyrosine kinase domain of the met proto-oncogene. J Urol. 2004 Oct; 172(4 Pt 1):1256-61. PMID: 15371818.
      View in: PubMed
    57. Warren MB, Torres-Cabala CA, Turner ML, Merino MJ, Matrosova VY, Nickerson ML, Ma W, Linehan WM, Zbar B, Schmidt LS. Expression of Birt-Hogg-Dubé gene mRNA in normal and neoplastic human tissues. Mod Pathol. 2004 Aug; 17(8):998-1011. PMID: 15143337.
      View in: PubMed
    58. Torres-Cabala C, Panizo-Santos A, Krutzsch HC, Barazi H, Namba M, Sakaguchi M, Roberts DD, Merino MJ. Differential expression of S100C in thyroid lesions. Int J Surg Pathol. 2004 Apr; 12(2):107-15. PMID: 15173915.
      View in: PubMed
    59. Vasselli JR, Shih JH, Iyengar SR, Maranchie J, Riss J, Worrell R, Torres-Cabala C, Tabios R, Mariotti A, Stearman R, Merino M, Walther MM, Simon R, Klausner RD, Linehan WM. Predicting survival in patients with metastatic kidney cancer by gene-expression profiling in the primary tumor. Proc Natl Acad Sci U S A. 2003 Jun 10; 100(12):6958-63. PMID: 12777628.
      View in: PubMed
    60. Torres C, Ro JY, Batt MA, Park YW, Ordonez NG, Ayala AG. Vascular adrenal cysts: a clinicopathologic and immunohistochemical study of six cases and a review of the literature. Mod Pathol. 1997 Jun; 10(6):530-6. PMID: 9195568.
      View in: PubMed
    61. Torres C, Ro JY, el-Naggar AK, Sim SJ, Weber RS, Ayala AG. Allergic fungal sinusitis: a clinicopathologic study of 16 cases. Hum Pathol. 1996 Aug; 27(8):793-9. PMID: 8760012.
      View in: PubMed
    62. Resistant mechanisms to BRAF inhibitor PLX4032 in melanoma. Expert Review of Dermatology. 6:355-357.
    63. Primary Cutaneous T-Cell Lymphomas Showing Gamma-Delta (γδ) Phenotype and Predominantly Epidermotropic Pattern are Clinicopathologically Distinct From Classic Primary Cutaneous γδ T-Cell Lymphomas. American Journal of Surgical Pathology.
    64. A case of indeterminate dendritic cell tumor presenting with leonine facies. Journal of Cutaneous Pathology. 43:158-163.
    65. Loss of CD30 expression after treatment with brentuximab vedotin in a patient with anaplastic large cell lymphoma. Journal of Cutaneous Pathology.
    66. Density, distribution, and composition of immune infiltrates correlate with survival in Merkel cell carcinoma. Clinical Cancer Research. 22:5553-5563.
    67. Primary Cutaneous Gamma-Delta (γ/δ) T-cell Lymphoma. American Journal of Dermatopathology.
    68. Giemsa is the optimal counterstain for immunohistochemical detection of BRAF V600E mutation status in pigmented melanomas. Journal of Cutaneous Pathology.
    69. Clinicopathological and molecular study of primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma. Journal of Cutaneous Pathology.
    70. Cutaneous metastasis from anaplastic thyroid carcinoma exhibiting exclusively a spindle cell morphology. A case report and review of literature. Journal of Cutaneous Pathology.
    71. Clinical significance of BRAF V600E mutational status in capsular nevi of sentinel lymph nodes in patients with primary cutaneous melanoma. Human Pathology. 59:48-54.
    72. Detection of Merkel Cell Polyoma Virus and Beta Human Papillomavirus in Multiple Eccrine Poromas in a Patient With Acute Leukemia Treated With Stem Cell Transplant. American Journal of Dermatopathology.
    73. Emerging clinical applications of selected biomarkers in melanoma. Clinical, Cosmetic and Investigational Dermatology. 8:35-46.
    74. Folliculotropic mycosis fungoides. Internet Journal of Dermatology. 8.
    75. Proliferation indices correlate with diagnosis and metastasis in diagnostically challenging melanocytic tumors. Human Pathology. 53:73-81.
    76. Concomitant Cutaneous Langerhans Cell Hystiocytosis and Leukemia Cutis. American Journal of Dermatopathology.
    77. Cutaneous histoplasmosis with prominent parasitization of epidermal keratinocytes. Journal of Cutaneous Pathology.
    78. Diverse types of dermatologic toxicities from immune checkpoint blockade therapy. Journal of Cutaneous Pathology. 44:158-176.
    79. Prognostic Implication of Lymphovascular Invasion Detected by Double Immunostaining for D2-40 and MITF1 in Primary Cutaneous Melanoma. American Journal of Dermatopathology.
    80. EBV-negative Aggressive NK-cell Leukemia/Lymphoma. American Journal of Surgical Pathology.
    81. High cytotoxic T-lymphocyte-associated antigen 4 and phospho-Akt expression in tumor samples predicts poor clinical outcomes in ipilimumab-treated melanoma patients. Melanoma Research.
    82. Cancer Discovery. 6:202-216.
    83. Role of radiotherapy in aggressive digital papillary adenocarcinoma. Annals of Clinical and Laboratory Science. 46:222-224.
    84. An unusual case of cytotoxic peripheral T-cell lymphoma. JAAD Case Reports. 1:257-260.
    85. Primär kutane CD30+ lymphoproliferative Erkrankungen. JDDG - Journal of the German Society of Dermatology. 14:767-784.
    86. Reply. Journal of Cutaneous Pathology. 37:916.
    87. Primary cutaneous CD30+ lymphoproliferative disorders. JDDG - Journal of the German Society of Dermatology. 14:767-782.
    TORRES CABALA's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description